Waters Corporation (NYSE: WAT) today unveiled two new data analysis software packages for proteomics and metabolomics/lipidomics analyses: Progenesis® QI and Progenesis QI for Proteomics. These new releases of the highly acclaimed software packages are an early result of Waters' acquisition of Nonlinear Dynamics Ltd., the world leader in 'omics data analysis software.
Progenesis QI software enables researchers to accurately quantify and identify compounds and proteins with unique methods to analyze and visualize LC-MS data. Supporting all common LC-MS data formats and with intuitive guided workflows, Progenesis QI software allows customers to rapidly, objectively and reliably discover compounds and proteins of interest in their valuable samples.
"The development of Progenesis QI is a great example of the innovation outcome for 'omics-focused scientists and laboratories that we at Waters envisioned when we combined Nonlinear Dynamics informatics expertise with Waters worldwide leadership in chromatography and mass spectrometry," said Dr. Rohit Khanna, Vice President of Informatics and WW Marketing for the Waters Division. "With these latest releases, we have combined the functionality of legacy 'omics-based data analysis software packages into a pair of stronger, broader reaching offerings. Progenesis QI maintains the heritage of previous releases and focuses our resources in delivering a suite of focused, world-leading informatics packages for 'omics data analysis."
In response to customer feedback, new features of Progenesis QI include fragment ion support for compound identification, automation of data processing workflows, and improvements in data import routines for enhanced signal differentiation over background noise. Furthermore, new abilities to utilize Waters' ion mobility data as well as MSE and HDMSE data independent analysis is a direct outcome of merging of Waters and Nonlinear Dynamics innovations.
Breastfeeding after COVID-19 vaccination is safe, with minimal changes to milk composition